CVS Health Restores Coverage for Eli Lilly's Zepbound

CVS Caremark, the pharmacy benefit manager of CVS Health (NYSE: CVS), announced it will restore coverage for Eli Lilly’s (NASDAQ: LLY) weight-loss drug Zepbound starting October 1. This decision is part of updates to its common commercial formularies.

By Dulan Lokuwithana, SA News Editor · Seeking Alpha · May 28, 2026, 11:35 UTC

CVS Health Restores Coverage for Eli Lilly's Zepbound

Tickers: $CVS $LLY

Topics: healthcare insurance coverage weight-loss drugs

Read the full article at Seeking Alpha

More World news

Nvidia CEO Jensen Huang Resigns Amid Board Investigation The Verge · November 12, 2026, 15:48 UTC
GFL Environmental Shares Decline Following Preferred Share Conversion and Block Trade Seeking Alpha · November 12, 2026, 15:48 UTC
Medical Facilities Corp. Announces CAD 0.09 Per Share Quarterly Dividend Seeking Alpha · November 12, 2026, 15:45 UTC
Micron Shares Decline Following Resignation of Nvidia CEO Jensen Huang Motley Fool · November 12, 2026, 15:44 UTC
Wirex Launches Navoka AI Agent with Dedicated Bank Account and Card PR Newswire · November 12, 2026, 15:44 UTC
Mobility Global Shares Rise 12% Following Q3 Earnings Beat and Improved EBITDA Outlook Seeking Alpha · November 12, 2026, 15:44 UTC
Lucid Diagnostics Reports Q3 2026 Results Amid Transition to Medicare Reimbursement Motley Fool · November 12, 2026, 15:39 UTC
National Vision Reports Q3 2026 Revenue Growth Driven by Higher Average Ticket Motley Fool · November 12, 2026, 15:40 UTC
Okeanis Eco Tankers Reports Record Q3 2026 Results Driven by High Freight Rates Motley Fool · November 12, 2026, 15:41 UTC
Nvidia Shares Plunge Following Resignation of CEO Jensen Huang Motley Fool · November 12, 2026, 15:35 UTC